Uses

Indicated as a combined oral contraceptive for the prevention of pregnancy in females of reproductive potential. May also be used for the treatment of moderate acne vulgaris in certain patients.

Do not use if

Contraindicated in women over 35 who smoke, patients with history of thromboembolic disease, stroke, hepatic impairment, known or suspected breast cancer, undiagnosed abnormal vaginal bleeding, and during pregnancy.

Side effects

Common adverse reactions include nausea, headache, breast tenderness, mood changes, and breakthrough bleeding. Serious risks include venous thromboembolism, stroke, and myocardial infarction, particularly in smokers and older users.

Warnings

Cigarette smoking significantly increases the risk of serious cardiovascular events. Not recommended for women over 35 who smoke. Discontinue if signs of thrombosis or liver dysfunction occur. Blood pressure monitoring is recommended during use.

How it works

Norgestimate is a third-generation progestogen with high progestogenic selectivity and low androgenic activity. Combined with ethinyl estradiol, it suppresses ovulation primarily by inhibiting the midcycle LH surge. It also alters cervical mucus and endometrial receptivity to reduce the chance of implantation.

Storage

Store below 25°C, protected from moisture and light. Keep out of reach of children.